Articles From: Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013 to Dell to Reimburse Icahn if He Drops Proxy Fight, Litigation Threats


2013/4/7
NKTR-214 Demonstrates Improved Efficacy in Resistant Preclinical Melanoma Model Through Preferential Activation of Tumor Killing Immune Cell Subtype SAN FRANCISCO , April 7, 2013 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today presented positive preclinical data for NKTR-214, a novel cancer immunotherapy which targets the IL-2 receptor complex, at the 2013 American Association for Cancer Research (AACR) Annual Meeting.
Sign-up for Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013 investment picks
2013/4/7
http://media.marketwire.com/attachments/201205/45309_43733_HP_Blue_RGB_72_MD.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1004386&ProfileId=051205&sourceType=1 LAS VEGAS, NV --
Sign-up for HP Leads Workstation Industry With Solutions for Creative Professionals investment picks
2013/4/7
Industry Leaders Enhance Application Performance in Visual Effects, Digital Content Creation and Computer Assisted Design for Demanding Creative Projects LAS VEGAS , April 7, 2013 /PRNewswire/ -- National Association of Broadcasters Tradeshow --
Sign-up for Fusion-io to Integrate ioFX Acceleration Into HP Z Workstations investment picks
2013/4/7
High Capacity ioFX Delivers Peak Performance for Professional Computer Graphics Applications including 4K Visual Effects Production, Stereoscopic 3D, Digital Intermediate, Computer Assisted Design and Video Editing LAS VEGAS , April 7, 2013 /PRNewswire/ -- [National Association of Broadcasters 2013 trade show] – Fusion-io (NYSE: FIO) today announced that the ioFX workstation acceleration platform is now available with 1.6 TB of capacity, in addition to the original 420 GB form factor.
Sign-up for Fusion-io Unveils 1.6 TB ioFX for Workstation Applications investment picks
2013/4/7
Getty Images SAN FRANCISCO (MarketWatch) — U.S. stocks, which reached all-time highs at the end of March, will face the first real test of their resiliency in the coming weeks as investors parse a flood of first-quarter earnings reports due to hit the market.
Sign-up for Earnings are 1st big stock test since market high investment picks
2013/4/7
TEL AVIV, Israel , April 7, 2013 /PRNewswire/ -- Elbit Imaging Ltd.
Sign-up for Elbit Imaging Announces Dispute Between Its Controlling Shareholders And Bank Hapoalim - Update investment picks
2013/4/6
- 208,000 square foot building houses 1,300 employees - and not a single office PHILADELPHIA , April 6, 2013 /PRNewswire/ -- GlaxoSmithKline (@GSKUS) officially opened its new double LEED® platinum certified facility in Philadelphia 's Navy Yard Corporate Center today, ushering in a new era of how people work in Philadelphia.
Sign-up for GlaxoSmithKline and Liberty Property Trust/Synterra Partners Transform the Work Environment with the Opening of Five Crescent Drive Today investment picks
2013/4/6
RIO DE JANEIRO --Marine fuel leaked late Friday from a refueling pier operated by Transpetro, the logistics unit of Brazilian oil company Petroleo Brasileiro (PBR, PETR4.BR, PETR3.BR), and soiled four beaches along the coast of Sao Paulo state, Transpetro said Saturday.
Sign-up for Brazil's Transpetro Detects Fuel Leak at Marine Refueling Pier investment picks
2013/4/6
BALA CYNWYD, Pa.
Sign-up for Law Office of Brodsky & Smith, LLC Announces Investigation of Sterling Bancorp, Inc. investment picks
2013/4/6
Chevrolet The 2014 Chevrolet C7 Corvette, which revives the Stingray name and will likely start around $50,000, replaces the former steel chassis with an advanced welded-aluminum structure.
Sign-up for 2014 Chevrolet Corvette: Drive All-American investment picks
2013/4/6
KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim results from a Phase IIIb, multicenter, open-label study (ATX-101-11-26) of ATX-101 during the “Innovations and Renewals” session of the 11 th Anti-Aging Medicine World Congress (AMWC), April 4-6, Monte Carlo, Monaco.
Sign-up for KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Phase IIIb Study of ATX-101 at the 11th Anti-Aging Medicine World Congress (AMWC) investment picks
2013/4/6
Keating Capital announces the following Webcast:   What: Webcast Presentation of Keating Capital (Nasdaq: KIPO)   When: April 9, 2013 @ 10:00 AM Eastern   Where: http://www.investorcalendar.com/ClientPage.asp?ID=170723 If you are unable to participate during the live webcast, the call will be available for replay at http://www.investorcalendar.com/ClientPage.asp?ID=170723 or http://www.investorcalendar.com/ .
Sign-up for Webcast Alert: Keating Capital Investor Presentation investment picks
2013/4/6
Glancy Binkow & Goldberg LLP announces that purchasers of the securities of Affymax, Inc. (“Affymax” or the “Company”) (NASDAQ:AFFY) between December 8, 2011 and February 22, 2013, inclusive (the “Class Period”), have until April 29, 2013 to file a motion with the Court to be appointed as lead plaintiff.
Sign-up for Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Affymax, Inc. investment picks
2013/4/6
Law Offices of Howard G.
Sign-up for Law Offices of Howard G. Smith Announces Class Action Lawsuit Against VeriFone Systems, Inc. investment picks
2013/4/5
The Law Offices of Todd M.
Sign-up for Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline in the Class Action Lawsuit Against ITT Educational Services, Inc. investment picks
2013/4/5
The Law Offices of Todd M.
Sign-up for Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline in the Class Action Lawsuit Against Maxwell Technologies, Inc. investment picks
2013/4/5
The Law Offices of Todd M.
Sign-up for Law Offices of Todd M. Garber Announces Investigation of Navistar International Corporation investment picks
2013/4/5
The Law Offices of Todd M.
Sign-up for Law Offices of Todd M. Garber Announces Investigation of Tech Data Corporation investment picks
2013/4/5
CI Investments announces response to the federal budget Canada NewsWire TSX Symbol: CIX TORONTO , April 5, 2013 /CNW/ - CI Investments Inc. ("CI") today announced a response to the recent federal budget.
Sign-up for CI Investments announces response to the federal budget investment picks
2013/4/5
The Law Offices of Todd M.
Sign-up for Law Offices of Todd M. Garber Announces Investigation of Atlantic Power Corporation investment picks
2013/4/5
Glancy Binkow & Goldberg LLP announces that purchasers of the securities of Spectrum Pharmaceuticals, Inc. (“Spectrum” or the “Company”) (NASDAQ:SPPI) between August 8, 2012 and March 12, 2013, inclusive (the “Class Period”), have until May 13, 2013 to file a motion with the Court to be appointed as lead plaintiff.
Sign-up for Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. investment picks
2013/4/5
The Law Offices of Todd M.
Sign-up for Law Offices of Todd M. Garber Announces Class Action Lawsuit Against Avid Technology, Inc. investment picks
2013/4/5
Glancy Binkow & Goldberg LLP announces that a class action lawsuit has been filed in the United States District Court for the District of Delaware on behalf of a class (the “Class”) comprising all purchasers of the common stock of Incyte Corporation (“Incyte” or the “Company”) (NASDAQ:INCY) between April 26, 2012 and August 1, 2012 (the “Class Period”). The Complaint alleges that certain statements issued by Incyte during the Class Period were false and misleading regarding the Company’s business and financial prospects.
Sign-up for Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Incyte Corporation investment picks
2013/4/5
The Law Offices of Todd M.
Sign-up for Law Offices of Todd M. Garber Announces Class Action Lawsuit Against Impax Laboratories, Inc. investment picks
2013/4/5
Glancy Binkow & Goldberg LLP announces that purchasers of the securities of Great Lakes Dredge & Dock Corporation (“Great Lakes” or the “Company”) (NASDAQ:GLDD) between August 7, 2012 and March 14, 2013, inclusive (the “Class Period”), have until May 20, 2013 to file a motion with the Court to be appointed as lead plaintiff.
Sign-up for Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Great Lakes Dredge & Dock Corporation investment picks
2013/4/5
Glancy Binkow & Goldberg LLP announces that purchasers of the common stock of Poseidon Concepts Corp.
Sign-up for Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Poseidon Concepts Corp. investment picks
2013/4/5
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of PulteGroup, Inc. (“PulteGroup” or the “Company”) (NYSE: PHM) (NYSE: PHA) for potential breaches of fiduciary duties in connection with their conduct in seeking shareholders’ approval for a Senior Management Incentive Plan and Stock Incentive Plan.
Sign-up for Faruqi & Faruqi, LLP Launches an Investigation against PulteGroup, Inc. (PHM) for Potential Breaches of Fiduciary Duties by Its Board of Directors investment picks
2013/4/5
SAO PAULO , April 5, 2013 /PRNewswire/ -- GOL Linhas Aereas Inteligentes S.A. (BM&FBOVESPA: GOLL4 and NYSE: GOL), (S&P: B, Fitch: B-, Moody's: B3), the largest low-cost and low-fare airline in Latin America , hereby announces that SMILES, its subsidiary that manages the Smiles Program, has formed partnerships with two major retail chains, Polishop and Cybelar.
Sign-up for Smiles Forms Partnerships with Polishop and Cybelar investment picks
2013/4/5
Dell Inc. (DELL) said it is willing to provide activist investor Carl Icahn with the same expense reimbursement that it has offered to its other two bidders, but only if Mr.
Sign-up for Dell to Reimburse Icahn if He Drops Proxy Fight, Litigation Threats investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013 to Dell to Reimburse Icahn if He Drops Proxy Fight, Litigation Threats
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity